T43.592A Poisoning by other antipsychotics and neuroleptics, intentional self-harm, initial encounter

Name of the Condition

• Poisoning by other antipsychotics and neuroleptics, intentional self-harm, initial encounter

Summary

This code applies to intentional self-harm poisoning from other antipsychotics or neuroleptics during the initial encounter. Antipsychotics and neuroleptics are used to treat psychiatric conditions, and intentional self-harm poisoning involves deliberate ingestion of these medications. Clinical documentation must specify the intentional self-harm nature and initial encounter for accurate coding.

Causes

Intentional self-harm poisoning by other antipsychotics or neuroleptics typically results from deliberate ingestion of the medication with the intent to cause harm. This may occur due to acute psychiatric distress, suicidal ideation, or attempts to self-medicate inappropriately. The "other" designation indicates the drug is not classified under more specific antipsychotic or neuroleptic categories.

Risk Factors

• Active suicidal ideation or prior suicide attempts
• Untreated or poorly managed psychiatric conditions (e.g., depression, bipolar disorder)
• Access to medications without supervision or secure storage
• History of substance use disorders
• Social isolation or lack of support systems
• Recent life stressors or crises

Symptoms

• Drowsiness or excessive sedation
• Confusion or altered mental status
• Rapid heart rate or irregular heartbeat
• Seizures or tremors
• Nausea, vomiting, or gastrointestinal distress
• Low blood pressure
• Respiratory depression or failure
• Coma

Diagnosis

Diagnosis relies on clinical evaluation, including patient history, physical examination, and laboratory tests. Documentation must confirm intentional self-harm and the initial encounter. Toxicology screens may identify the specific antipsychotic or neuroleptic involved. Imaging or other tests may assess organ damage or complications.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and addressing the underlying psychiatric condition. Interventions may include activated charcoal, supportive care (e.g., airway management, IV fluids), and psychiatric evaluation. Long-term care often involves therapy, medication management, and safety planning.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, timeliness of treatment, and underlying mental health status. Follow-up includes ongoing psychiatric care, medication adjustments, and monitoring for recurrence. Discharge planning may involve crisis intervention services or outpatient therapy.

Complications

• Respiratory failure or arrest
• Cardiac arrhythmias or myocardial injury
• Seizures or neurological damage
• Organ toxicity (e.g., liver, kidney)
• Worsening of psychiatric conditions
• Risk of future self-harm or suicide

Lifestyle & Prevention

• Secure storage of medications to limit access
• Regular psychiatric follow-up and medication reviews
• Education on safe medication use and disposal
• Building support networks and coping strategies
• Crisis hotlines or emergency contacts for at-risk individuals

When to Seek Professional Help

Seek immediate medical attention for suspected poisoning, especially with intentional self-harm. Signs include altered consciousness, difficulty breathing, seizures, or known ingestion of antipsychotics/neuroleptics. Prompt care improves outcomes and reduces complications.

Tips for Medical Coders

Document the intentional self-harm nature and initial encounter clearly. Code T43.592A requires confirmation of deliberate ingestion and the first encounter for treatment. Ensure documentation specifies the "other" antipsychotic/neuroleptic category and excludes more specific drug codes.